A pharmaceutical company is investing in a new manufacturing site in Texas. The site is planned by Bristol Myers Squibb and is valued at $2.3 billion.

Further information about the project is available from the New Jersey Business & Industry Association.

Details about the site's location within Texas and other specifics are not provided in the initial announcement, but more information can be found through the association's resources.